KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Consolidated Net Income (2016 - 2026)

Alnylam Pharmaceuticals filings provide 18 years of Consolidated Net Income readings, the most recent being $206.0 million for Q1 2026.

  • Quarterly Consolidated Net Income rose 1228.66% to $206.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $543.9 million through Mar 2026, up 336.01% year-over-year, with the annual reading at $313.7 million for FY2025, 212.79% up from the prior year.
  • Consolidated Net Income hit $206.0 million in Q1 2026 for Alnylam Pharmaceuticals, up from $111.5 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $292.7 million in Q3 2025 and bottomed at -$405.9 million in Q3 2022.
  • Average Consolidated Net Income over 5 years is -$77.9 million, with a median of -$83.8 million recorded in 2024.
  • The largest annual shift saw Consolidated Net Income plummeted 292.43% in 2025 before it skyrocketed 1228.66% in 2026.
  • Alnylam Pharmaceuticals' Consolidated Net Income stood at -$207.5 million in 2022, then skyrocketed by 33.55% to -$137.9 million in 2023, then skyrocketed by 39.24% to -$83.8 million in 2024, then surged by 233.17% to $111.5 million in 2025, then surged by 84.67% to $206.0 million in 2026.
  • Per Business Quant, the three most recent readings for ALNY's Consolidated Net Income are $206.0 million (Q1 2026), $111.5 million (Q4 2025), and $292.7 million (Q3 2025).